| Financial Year |
March 31 2023 |
| Monetary Funds |
230,236,924.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
132,253,171.60 |
| Advances to Suppliers |
10,347,969.11 |
| Other Receivables |
4,074,142.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,400,819.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,376,785.46 |
| Total Current Assets |
556,238,884.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,584,327.99 |
| Investment Properties |
-- |
| Fixed Assetes |
202,601,595.83 |
| Under-construction Projects |
826,424.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,676,719.84 |
| R&D expenses |
-- |
| Goodwill |
53,298,219.71 |
| Long-Term Deferred and Prepaid Expenses |
1,105,821.42 |
| Deferred Income Tax Assets |
2,190,935.18 |
| Other Non-Current Assets |
564,440.40 |
| Sub-Total of Non-Current Assets |
342,304,102.76 |
| Total Assets |
898,542,987.49 |
| Short-Term Loans |
59,687,110.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
56,745,292.04 |
| Accounts Payable |
41,143,544.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,435,104.37 |
| Taxes Payable |
8,351,176.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,391,815.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,787,724.78 |
| Other Current Liabilities |
1,858,022.89 |
| Sub-Total of Current Liabilities |
292,700,221.04 |
| Long-term Loans |
-- |
| Bonds Payable |
135,465,973.82 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,289,497.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
145,532,872.51 |
| Total Liabilities |
438,233,093.55 |
| Paid-In Capital(Or Share Stock) |
138,439,277.00 |
| Capital Surplus |
132,480,334.54 |
| Surplus Reserve |
26,897,531.92 |
| LESS:Treasury Stock |
1,302,403.80 |
| Undistributed Profits |
130,660,015.49 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
460,309,893.94 |
| Owner's Equity（Stockholder's Equity） |
460,309,893.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
898,542,987.49 |
